HIV infection in macrophage: Role of long-lived cells and related therapeutical strategies

Journal of Biological Regulators and Homeostatic Agents

Volumn 11, Issue 1-2, 1997, Pages 69-73

  Aquaro, S ^a   Balestra, E ^a   Cenci, A ^a   Francesconi, M ^b   Calio R ^a   Perno, C F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Frascati Hospital   (Italy)

Author keywords

AIDS dementia complex; Anti viral therapy; Central nervous system; HIV reservoir; Protease inhibitors

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; ZIDOVUDINE;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG TISSUE LEVEL; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LATENT VIRUS INFECTION; LYMPH NODE; MACROPHAGE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030828620     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986; 233: 215-9.
2. Ho DD, Rota TR, Hirsch MS. Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin-Invest 1986; 77: 1712-5.
3. Perno CF, Yarchoan R, Cooney DA, et al. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides. J Exp Med 1988; 168: 1111-2.
4. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233: 1089-93.
5. Vazeux R, Brousse N, Jarry A, et al. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987; 126: 403-10.
6. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990; 8: 169-94.
7. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984 2: 370-2.
8. Tschachler E, Groh V, Popovic M, et al. Epidermal Langerhans cells-a target for HTLV-III/LAV infection. J Invest Dermatol 1987 88: 233-7.
9. Meltzer MS, Nakamura M, Hansen BD, Turpin JA, Kalter DC, Gendelman HE. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses 1990; 6: 967-71.
10. McElrath MJ, Pruett JE, Cohn ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci USA 1989; 86: 675-9.
11. Mattern CF, Murray K, Jensen A, Farzadegan H, Pang J, Modlin JF. Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 1992; 89: 207-9.
12. Gabuzda DH, Hirsch MS. Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med 1987; 107: 383-91.
13. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250: 1593-6.
14. Tyor WR, Power C, Gendelman HE, Markham RB. A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci USA 1993; 90: 8658-62.
15. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332: 934-40.
16. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387: 188-91.
17. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387: 183-8.
18. Navia BA, Cho ES, Petito CK, Price RW The AIDS dementia complex: II. Neuropathology Ann Neurol 1986; 19: 525-35.
19. Gabuzda DH, Ho DD, De la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986; 20: 289-95.
20. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089-93.
21. Kure K, Lyman WD, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990; 136: 1085-92.
22. Saito Y, Sharer LR, Epstein LG, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44: 474-81.
23. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44: 481-7.
24. Nottet HS, Gendelman HE. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex Immunol Today 1995; 16: 441-8.
25. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992; 42: 1472-6.
26. McArthur JC. HIV Dementia: Incidence and Risk Factors in HIV, AIDS, and the Brain. New York, Raven Press, 1994; p: 251-72.
27. Price RW. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex. Journal of neuro-AIDS 1996; 1: 1-20.
28. Sinclair E, Gray F, Ciardi A, Scaravilli FJ. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. Neuropathol-Exp Neurol 1994; 53: 43-50.
29. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991; 64: 135-56.
30. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta-Neuropathol-Berl 1990; 80: 393-400.
31. Sharer LR. Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992; 51: 3-11.
32. Balter M. HIV's other immune-system targets: macrophages. Science 1996; 274: 1464-5.
33. Nottet HS, Persidsky Y, Sasseville VG, et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996; 156: 1284-95.
34. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol 1996; 157: 974-7.
35. Everall I, Luthert P, Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol-Exp Neurol 1993; 52: 561-6
36. Masliah E, Ge N, Achim CL, De Teresa R, Wiley CA. Patterns of neurodegeneration in HIV encephalitis. J Neuro AIDS 1996, 1: 161-73.
37. Dickson DW, Lee SC. Microglia in HIV-related CNS neuropathology: An update. J Neuro AIDS 1996 1: 57-84.
38. Aquaro S, Perno CF, Balestra E, et al. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J Leukoc Biol 1997; 62: 138-43.
39. O'Brien WA, Namazi A, Kalhor H, Mao SH, Zack JA, Chen IS. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 1994; 68: 1258-63.
40. Bagnarelli P, Valenza A, Menzo S, et al. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol 1996; 70: 7603-13.
41. Perno CF, Baseler MW, Broder S, Yarchoan R. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies. J Exp Med 1990; 171: 1043-56.
42. Perno CF, Cooney DA, Gao WY, et al. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 1992; 80: 995-1003.
43. Yarchoan R, Berg G, Brouwers P, et al. Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet 1997; 1: 132-5.
44. Pizzo PA; Eddy J, Falloon J, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319: 889-96.
45. Federici ME, Kline MW, Rutkiewicz VL, et al. A phase I/II evaluation of stavudine (d4T) in children with HIV infection. Int Antiv News 1996; 4: 109-111.
46. Persidsky Y, Limoges J, McComb R, et al. Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol, 1996; 149: 1027-53.
47. Perno CF, Aquaro S, Rosenwirth B, et al. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol 1994; 56: 381-6.
48. Perno CF, Bergamini A, Pesce CD, et al. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J Infect Dis 1993; 168: 1148-56.
49. Perno CF, Aquaro S, Cenci A, et al. Development of resistance to anti-HIV drugs in primary macrophages. Proc. Tenth International Conference on Antiviral Research, Atlanta, Georgia, U.S.A 1997; April 6-11.
50. Rayner MM, Cordova BC, Meade RP, et al. DMP 323, a non-peptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein. Antimicrob Agents Chemother 1994; 38: 1635-40
51. El-Farrash MA, Kuroda MJ, Kitazaki T, et al. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J Virol 1994; 68: 233-9.
52. Kort JJ, Bilello JA, Bauer G, Drusano GL. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother 1993; 37: 115-9.
53. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997; 277: 1962-9.